AS Latvijas Juras medicinas centrs (UOM) — Capital Reinvestment Ratio
AS Latvijas Juras medicinas centrs (UOM) has a Capital Reinvestment Ratio of 0.91x as of September 2025, meaning it reinvests 1% of its operating cash flow (€474.45K) in capital expenditures (€430.89K). Check UOM tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
AS Latvijas Juras medicinas centrs Capital Reinvestment Ratio (2015–2024)
This chart tracks AS Latvijas Juras medicinas centrs's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see how efficiently does AS Latvijas Juras medicinas centrs generate cash.
Annual Capital Reinvestment Ratio for AS Latvijas Juras medicinas centrs (2015–2024)
Year-by-year Capital Reinvestment Ratio for AS Latvijas Juras medicinas centrs from 2015 to 2024. See AS Latvijas Juras medicinas centrs free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.72x | €605.02K | €436.21K | ▼ -44.4% |
| 2023 | 1.30x | €1.91 Million | €2.48 Million | ▲ +125.1% |
| 2022 | 0.58x | €1.09 Million | €629.72K | ▼ -78.3% |
| 2021 | 2.65x | €418.24K | €1.11 Million | ▲ +277.5% |
| 2020 | 0.70x | €732.71K | €515.12K | ▲ +52.6% |
| 2019 | 0.46x | €412.86K | €190.16K | ▲ +219.4% |
| 2018 | 0.14x | €599.57K | €86.45K | ▼ -88.6% |
| 2017 | 1.27x | €478.41K | €605.51K | ▼ -38.4% |
| 2016 | 2.06x | €418.49K | €860.13K | ▲ +186.4% |
| 2015 | 0.72x | €362.36K | €260.06K | — |